Compare Abeona Therapeutics Inc (ABEO) vs Zillow Group Inc Class C (Z) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Zillow Group Inc Class C — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Zillow Group Inc Class C trades at $33.89 (market cap $7.68B). The key difference: Zillow Group Inc Class C is far larger — about 18.2× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Zillow Group Inc Class C nearer its low. Which is the better fit depends on your goals.
| ABEO | Z | |
|---|---|---|
Market Cap | $421.19M | $7.68B |
Sector | Health | Media |
52-Week High | $7.45 | $90.35 |
52-Week Low | $4.17 | $29.41 |
Enterprise Value | $276.10M | $7.56B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Zillow Group Inc Class C
Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →
